Seasonal influenza virus vaccine trivalent - Fluart Innovative Vaccines

Drug Profile

Seasonal influenza virus vaccine trivalent - Fluart Innovative Vaccines

Alternative Names: FAB 3511; FAB 6011; FAB 9011; FLUVAL AB; FLUVAL K; Intransal seasonal influenza virus vaccine - Fluart Innovative Vaccines; Low-dose seasonal influenza virus vaccine trivalent - Fluart Innovative Vaccines; Nazoflu; Trivalent seasonal influenza virus vaccine - Fluart Innovative Vaccines

Latest Information Update: 15 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Omninvest
  • Developer Fluart Innovative Vaccines; Omninvest
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 17 Jan 2017 No development reported - Phase-III for Influenza virus infections (In adolescents, In children, Prevention) in Hungary (IM)
  • 15 Oct 2014 Phase-III clinical trials in Influenza virus infections (Prevention, In children, In adolescents) in Hungary (IM)
  • 07 Feb 2014 No development reported - Registered for Influenza virus infections in Hungary (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top